Abstract
Aortic pulse wave velocity (Ao-PWV) and ankle-brachial blood pressure index (ABPI) are significant prognostic factors in patients with end-stage renal disease (ESRD). Diabetes mellitus (DM) promotes changes in arterial walls, including marked increases in Ao-PWV and decreases in ABPI. To determine the prevalence of peripheral arterial occlusive disease (PAOD) as well as the clinical variables useful in predicting these changes in nondiabetic patients with ESRD undergoing hemodialysis (HD), we performed a cross-sectional study in a cohort of 143 patients. Ao-PWV and ABPI were measured simultaneously and compared with several annual biochemical measurements and other clinical variables. The prevalence of PAOD in our cohort was 30.5%. In univariate regression analysis, Ao-PWV correlated positively with age, heart rate (HR), blood pressure (BP), pulse pressure (PP) and HbA1c, and negatively with serum albumin and ABPI. ABPI correlated negatively with age, HD duration, systolic BP, PP, low-density lipoprotein (LDL) cholesterol and hypersensitive C-reactive protein (hs-CRP), and positively with serum albumin and bone mineral density. In a step-down multiple regression analysis, HbA1c was identified as an independent determinant of Ao-PWV along with age, HD duration, HR and mean BP, while hs-CRP was an independent contributor to ABPI along with age, HD duration, PP and LDL cholesterol. Our results suggest that HD promotes aortic wall stiffness and PAOD progression. We recommend the monitoring of HbA1c to allow the prediction of aortic wall stiffness in nondiabetic ESRD patients. Our results did not confirm the influence of insulin resistance on the development of arterial sclerosis lesions.
Similar content being viewed by others
Article PDF
References
Lindner A, Charra B, Sherrard DJ, Scribner BH : Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701.
Nakai S, Shinzato T, Nagura Y, et al, Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo : An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial 2004; 8: 3–32.
Meyer KB, Levey AS : Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease. J Am Soc Nephrol 1998; 9: S31–S42.
Luke RG : Chronic renal failure—a vasculopathic state. N Engl J Med 1998; 339: 841–843.
Yamashina A, Tomiyama H, Arai T, et al: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615–622.
Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM : Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434–2439.
Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB : Decreased ankle/arm pressure index and mortality in elderly woman. JAMA 1993; 270: 465–469.
Cui R, Iso H, Yamagishi K, et al: Ankle-arm blood pressure index and cardiovascular risk factors in elderly Japanese men. Hypertens Res 2003; 26: 377–382.
Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK : Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 1999; 27: 668–672.
Testa A, Ottavioli JN : Ankle-arm blood pressure index (AABPI) in hemodialysis patients. Arch Mal Coeur Vaiss 1998; 91: 963–965.
Excerpts from United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999; 34: S1–S176.
Johnson JG, Gore SM, Firth J : The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant 1999; 14: 2156–2164.
Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC : Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202–208.
Vitelli LL, Shahar E, Heiss G, et al: Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study. Diabetes Care 1997; 20: 1454–1458.
Chan MC, Gao SZ, Schroeder JS, et al: Glucose intolerance, as reflected by hemoglobin a1c level, is associated with the incidence and severity of transplant coronary artery disease. J Am Coll Cardiol 2004; 43: 1034–1041.
Goldstein DE, Little RR, Lorenz RA, et al: Tests of glycemia in diabetes. Diabetes Care 2004; 27: 1761–1773.
Hasegawa M : Fundamental studies on pulse wave velocity of human aorta. Jikei Med J 1970; 85: 742–760.
Nye E : The effect of pressure alteration on the pulse wave velocity. Br Heart J 1964; 26: 261–265.
Cheung AK, Yan G, Greene T, et al: Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol 2002; 13: 2345–2352.
Desmeules S, Arcand-Bosse JF, Bergeron J, Douville P, Agharazii M : Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis 2005; 45: 1067–1072.
Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM : Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535–541.
Level C, Lasseur C, Delmas Y, et al: Determinants of arterial compliance in patients treated by hemodialysis. Clin Nephrol 2001; 56: 435–444.
Nitta K, Akiba T, Uchida K, et al: Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 2004; 27: 47–52.
Nitta K, Akiba T, Suzuki K, et al: Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res 2004; 27: 527–533.
Saijo Y, Utsugi M, Yoshioka E, et al: Relationship of β2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res 2005; 28: 505–511.
Menon V, Greene T, Pereira AA, et al: Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease (CKD). J Am Soc Nephrol 2005; 16: 3411–3417.
Nakanishi N, Shiraishi T, Wada M : Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh Study. Hypertens Res 2005; 28: 125–131.
Seo HS, Kang TS, Park S, et al: Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res 2005; 28: 945–951.
Fujiwara T, Saitoh S, Takagi S, et al: Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia. Hypertens Res 2005; 28: 665–670.
Shinohara K, Shoji T, Emoto M, et al: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894–1900.
Al Zahrani HA, Al Bar HMS, Bahnassi A, Abdulaal AA : The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. Int Angiol 1997; 16: 123–128.
Ono k, Tsuchida A, Kawai H, et al: Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003; 14: 1591–1598.
Cheung AK, Sarnak MJ, Yan G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353–362.
Lagrand WK, Visser CA, Hermens WT, et al: C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon. Circulation 1999; 100: 96–102.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH : Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425–428.
Wildman RP, Muntner P, Chen J, Sutton-Tyrrell K, He J : Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999–2002. Am J Cardiol 2005; 96: 1579–1583.
Yeun JY, Levine RA, Mantadilok V, Kaysen GA : C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35: 469–476.
Menon V, Greene T, Wang X, et al: C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005; 68: 766–772.
Takenaka T, Kobayashi K, Suzuki H : Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients. Atherosclerosis 2004; 176: 405–409.
Guerin AP, London GM, Marchais SJ, Metivier F : Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014–1021.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsumae, T., Abe, Y., Murakami, G. et al. Determinants of Arterial Wall Stiffness and Peripheral Artery Occlusive Disease in Nondiabetic Hemodialysis Patients. Hypertens Res 30, 377–385 (2007). https://doi.org/10.1291/hypres.30.377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.377
Keywords
This article is cited by
-
What factors accelerate aortic stiffening in hemodialysis patients? An observational study
Hypertension Research (2010)